EV/EBITDA
-1.30
+0.05+3.70%
6 min ago
Summary
- As of March 7, 2025, RLAY EV/EBITDA is -1.30, with a rise of +0.05 (+3.70%) during the most recent trading day.
- Over the past year, RLAY EV/EBITDA has increased by +2.05 (+61.19%).
- RLAY EV/EBITDA is now -5.69% below its all-time high of -1.23.
Performance
RLAY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RLAY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.7% | -3.6% | -3.2% |
| 1 m1 month | +26.6% | -26.5% | -24.6% |
| 3 m3 months | +23.5% | -25.2% | -26.3% |
| 6 m6 months | +31.6% | -33.0% | -46.4% |
| ytdytd | +20.7% | -20.8% | -19.4% |
| 1 y1 year | +61.2% | -59.3% | -66.5% |
| 5 y5 years | - | - | - |
RLAY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.7% | -1.79 | +27.4% | |
| 3 m | 3-month | -1.23 | -5.7% | -2.05 | +36.6% |
| 6 m | 6-month | -1.23 | -5.7% | -3.20 | +59.4% |
| 1 y | 1-year | -1.23 | -5.7% | -3.51 | +63.0% |
| 3 y | 3-year | -1.23 | -5.7% | -14.86 | +91.3% |
| 5 y | 5-year | -1.23 | -5.7% | -97.78 | +98.7% |
| alltime | all time | -1.23 | -5.7% | -97.78 | +98.7% |
Relay Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.30(-20.7%) |
| 2024 | -1.64(-55.7%) |
| 2023 | -3.70(-33.8%) |
| Date | Value |
|---|---|
| 2022 | -5.59(-59.3%) |
| 2021 | -13.74(-78.3%) |
| 2020 | -63.42 |
FAQ
- What is Relay Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Relay Therapeutics?
- What is RLAY EV/EBITDA year-to-date change?
- What is Relay Therapeutics EV/EBITDA year-on-year change?
What is Relay Therapeutics EV/EBITDA?
The current EV/EBITDA of RLAY is -1.30
What is the all time high EV/EBITDA for Relay Therapeutics?
Relay Therapeutics all-time high EV/EBITDA is -1.23
What is RLAY EV/EBITDA year-to-date change?
Relay Therapeutics EV/EBITDA has changed by +0.34 (+20.73%) since the beginning of the year
What is Relay Therapeutics EV/EBITDA year-on-year change?
Over the past year, RLAY EV/EBITDA has changed by +2.05 (+61.19%)